Reaktionsgleichung
[C:1]([O:6][C@H:7]([CH2:9][CH2:10][CH2:11][CH2:12][C@@H:13]([O:16][C:17](=[O:21])[CH2:18][CH2:19][CH3:20])[CH2:14][CH3:15])[CH3:8])(=[O:5])[CH2:2][CH2:3][CH3:4].C1O[C@@H]1C.BrCCCC=C>>[C:1]([O:6][CH:7]([CH2:9][CH2:10][CH2:11][CH2:12][CH:13]([O:16][C:17](=[O:21])[CH2:18][CH2:19][CH3:20])[CH2:14][CH3:15])[CH3:8])(=[O:5])[CH2:2][CH2:3][CH3:4]Komponenten
Versuchsvorschrift
FIG. 5 illustrates the scheme for the synthesis of field-active (2S,7S)2,7-nonanediyl dibutyrate (14): S-propylene oxide (6) (Fluka Chemika-Biochemika, Buchs, Switzerland) was coupled at −20° C. with Grignard reagent 7 in the presence of 0.1 equivalents of a CuI catalyst. Resulting (2S)-8-octen-2-ol (8) was oxidized by m-chloroperoxybenzoic acid (Aldrich Chemical Co.) to the terminal epoxide 9. Hydrolytic kinetic resolution of 9 with Co(II) salen (Jacobsen's) catalyst (R,R)N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoc (10) (Aldrich Chemical Co.) (24, 25) afforded 2(R),7(S)-1,2-epoxy-7-hydroxyoctane (11), which was separated from unwanted 1,2(S),7(S)-octanetriol (12) by silica flash chromatography [hexane: ether (1:1), then ether as eluents]. Ring opening of 11 with excess of methylmagnesium bromide (Aldrich Chemical Co.) and catalytic amounts of Cul yielded (2S,7S)-2,7-nonanediol (13) which was esterified to (2S,7S)-2,7-nonanediol dibutyrate [14; 77% enantiomeric excess (ee) as determined by chiral GC; 37% overall yield]. GC-MS and NMR data of 14 were consistent with those of 5 (FIG. 4). The remaining 3 stereoisomers of diester 5 were synthesized from (S)- or (R)-propylene oxide (Fluka Chemika-Biochemika) and 5-bromo-pentene (Aldrich Chemical Co.), again by hydrolytic kinetic resolution of terminal epoxide intermediates, with ee of end products ranging between 73-85%.
Quellen und Nachweise
- ORD-Eintrag
- ord-a24dfb6ed47344e79566532cf25691a7
- Quelldatensatz
- uspto-grants-2001_10
- Patentnummer
- US06310003B1
Verknüpfte Notizen
Wird geladen…